Compare STTK & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | SHIM |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.9M | 123.6M |
| IPO Year | 2020 | 2023 |
| Metric | STTK | SHIM |
|---|---|---|
| Price | $3.95 | $3.96 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.20 | N/A |
| AVG Volume (30 Days) | ★ 319.7K | 58.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.32 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,721,000.00 | ★ $480,236,000.00 |
| Revenue This Year | N/A | $6.91 |
| Revenue Next Year | N/A | $13.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 245.26 | N/A |
| 52 Week Low | $0.69 | $1.30 |
| 52 Week High | $4.89 | $4.47 |
| Indicator | STTK | SHIM |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 55.78 |
| Support Level | $3.52 | $3.35 |
| Resistance Level | $4.23 | $4.10 |
| Average True Range (ATR) | 0.28 | 0.27 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 23.85 | 56.60 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.